Babcock International (LON: BAB) shares gained on Wednesday after the company secured a £1 billion contract extension with the UK Ministry of Defence (MOD) to support the British Army. 

The FTSE 100 is pushing up towards 8,700 this morning, with gains of 0.62% propelling the index 53 points to 8,691. Having fallen below the level on Friday, the bulls

Bank of America downgraded Vodafone (LON: VOD) shares from Buy to Neutral in a note this week, citing concerns over the financ

AO World (LON: AO.) shares rose around 2.4% in early Tuesday trading after the electricals retailer said full-year profit is expected to be at the top end of its guidance range, supported by strong retail sales growth.

GSK plc (LON: GSK) has announced a significant development concerning its asthma medication, Nucala, which is being considered for expanded use. The European Medicines Agency (EMA) has accepted the company's application to br

WPP (LON: WPP), the FTSE 100-listed advertising and marketing firm, is looking to sell its in-flight entertainment provider Spafax as part of a broader effort to reshape the business, according to a report from Sky News on Fr

Crest Nicholson's (LON: CRST) turnaround plan under its new Chief Executive has prompted RBC Capital to upgrade the stock to Outperform.  [stock_market_widget type="chart" tem

The first few months of 2025 has seen Shell's share price (LON: SHEL) climb 7.96%, albeit seemingly stuck in a trading range that has held for the past 6 months or so.

Babcock' shares (LON: BAB) have started the year with huge gains, as a run up that stretches to 44.5% has brought new 52 week highs in the process. With an ever growing market cap, Babcock is set to replace Hargreaves Lansdow

QinetiQ (LON: QQ.) shares faced further pressure as multiple analysts cut their price targets following the defence contractor’s profit warning earlier this week. Deutsche

Asos (LON: ASC) extended Thursday’s rally on Friday, following news that the online fashion retailer expects first-half earnings to exceed analyst expectations. [stock_market_

Wickes (LON: WIX) shares climbed more than 6% on Thursday morning after the home improvement retailer reported full-year results showing adjusted profit before tax (PBT) at the upper end of expectations. 

Crest Nicholson (LON: CRST) shares are rising Thursday, aiming to continue the bounce from their recent lows after reporting an encouraging start to the year and outlining a refreshed strategy for growth at its Capital Market

BP's shares (LON: BP) have taken a mild 0.24% dip through this morning's session after a 6.3% rally in the week leading in. The past year paints a more complicated story

BAE Systems shares (LON: BA) have been a huge outperformer so far this year, with gains of 46.73% YTD a far cry from 2024, where the price gained single digits.

Filtronic (AIM: FTC) shares gained over 5% to around 110p on Tuesday after the company announced an expanded strategic agreement with Elon Musk’s SpaceX to supply advanced technology for the Starlink satellite constellation.

Barclays downgraded Centrica (LON: CNA) to Equal Weight from Overweight in a note this week, lowering its price target for the stock from 175p to 170p a share.  [stock_market_

Diageo (LON: DGE), the global spirits giant behind brands like Johnnie Walker, Guinness, and Smirnoff, is facing a period of significant turbulence. The company's stock has been on a downward trajectory for the past year, she

Glencore (LON: GLEN), a major player in the commodities sector, has made an offer to acquire Li-Cycle, a Canadian company specialising in lithium battery recycling. Li-Cycle, in response, has set up a special committee to eva

Bernstein analysts have raised their rating for National Grid (LON: NG.) to Outperform, projecting a potential 17% upside in the company's share price from Friday’s close. 

Despite falling around 8% in the last month, RELX (LON: REL) stock is said to look "incrementally attractive" at current levels. Barclays upgraded RELX from Equal-Weight to

Trainline (LON: TRN) shares have taken a significant hit this year, plunging over 36% year-to-date, with a 13% drop last Thursday as concerns over slowing ticket sales growth and the potential impact of a state-backed ticketi

AstraZeneca (LON: AZN) said Monday that it has agreed to acquire EsoBiotec in a deal worth up to $1 billion.  AstraZeneca will pay $425 million upfront, with up to $575 mil